Fish oil supplements for heart health have been widely promoted for decades, yet recent evidence presents a more nuanced picture than early research suggested. These supplements, derived from oily fish tissues, contain omega-3 polyunsaturated fatty acids—primarily EPA and DHA—which may influence cardiovascular function through several mechanisms. Whilst observational studies initially indicated substantial benefits, large-scale randomised controlled trials have yielded mixed results. Current UK guidance emphasises dietary fish consumption over routine supplementation for most people. Understanding who might benefit, what the evidence actually shows, and how fish oil supplements compare to other cardiovascular interventions is essential for making informed decisions about heart health.

What Are Fish Oil Supplements and How Do They Work?

Fish oil supplements are dietary products derived from the tissues of oily fish, including mackerel, herring, sardines, salmon and anchovies. These supplements are rich in omega-3 polyunsaturated fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These essential fatty acids cannot be synthesised efficiently by the human body and must therefore be obtained through diet or supplementation.

The potential cardiovascular effects of omega-3 fatty acids may occur through several mechanisms, though it's important to note that these mechanistic effects do not necessarily translate into proven reductions in cardiovascular events. EPA and DHA are incorporated into cell membranes throughout the body, where they may influence membrane fluidity and cellular signalling. They appear to have anti-inflammatory properties, potentially reducing the production of pro-inflammatory cytokines and eicosanoids. Some evidence suggests omega-3 fatty acids may help to lower triglyceride levels, reduce blood pressure modestly, and possibly improve endothelial function—the ability of blood vessels to dilate appropriately.

Some research suggests fish oil may have mild antiarrhythmic effects, though the evidence is inconsistent and higher doses have paradoxically been associated with increased risk of atrial fibrillation in recent clinical trials. Omega-3s may have mild effects on platelet function, though these are much less pronounced than with antiplatelet medications. The supplements are available in various formulations, including standard fish oil capsules, concentrated EPA/DHA preparations, and prescription-strength products.

It is important to note that whilst fish oil supplements contain omega-3 fatty acids, they differ from eating whole fish, which provides additional nutrients including protein, vitamin D, selenium and other beneficial compounds. The evidence base for supplements versus dietary fish consumption shows some important distinctions in cardiovascular outcomes. Additionally, DHA-containing omega-3 supplements may increase LDL-cholesterol in some individuals, whereas EPA-only formulations have different lipid effects.

Evidence for Fish Oil Supplements in Heart Health

The evidence for fish oil supplements in cardiovascular disease prevention has evolved considerably over recent decades, with more recent large-scale trials providing important clarification. Early observational studies suggested substantial cardiovascular benefits from omega-3 fatty acid consumption, largely based on populations with high dietary fish intake. However, randomised controlled trials of supplementation have yielded more nuanced findings.

For secondary prevention—in people with established cardiovascular disease—the evidence remains mixed. Some earlier trials, such as GISSI-Prevenzione, suggested modest benefits in reducing cardiovascular mortality following myocardial infarction. However, more recent meta-analyses, including Cochrane reviews, have found little to no significant benefit of omega-3 supplements in preventing further cardiovascular events in people with existing heart disease. The STRENGTH trial (2020) and OMEMI trial (2021) both failed to demonstrate cardiovascular benefits from omega-3 supplementation in high-risk populations.

For primary prevention—preventing heart disease in healthy individuals—the evidence is similarly limited. Large trials including VITAL (2019) and ASCEND (2018) found no significant reduction in major cardiovascular events with omega-3 supplementation. However, the REDUCE-IT trial (2019) showed that high-dose purified EPA (icosapent ethyl, a prescription medicine) significantly reduced cardiovascular events in people with elevated triglycerides on statin therapy. Importantly, this prescription medication differs from standard over-the-counter fish oil supplements and is now recommended by NICE (TA805) for adults with established cardiovascular disease and raised triglycerides (typically 1.7-5.6 mmol/L) who are taking statins. It should be noted that both REDUCE-IT and STRENGTH trials observed an increased risk of atrial fibrillation with higher-dose omega-3 treatment.

NICE guidance (NG238) does not recommend routine omega-3 supplementation for cardiovascular disease prevention. The focus remains on dietary sources of omega-3 fatty acids, with recommendations to consume at least two portions of fish weekly, including one portion of oily fish. This approach provides omega-3 fatty acids alongside other beneficial nutrients found in whole foods.

Who Should Consider Fish Oil Supplements for Cardiovascular Support?

The decision to use fish oil supplements should be individualised, considering dietary intake, cardiovascular risk factors and existing medical conditions. People who may benefit most include those with established cardiovascular disease and raised triglycerides (typically 1.7-5.6 mmol/L) despite statin therapy, who may be eligible for prescription icosapent ethyl (a purified EPA product) under NICE guidance (TA805). This prescription medicine should not be confused with standard over-the-counter fish oil supplements.

People with very high triglycerides (persistently above 10 mmol/L) warrant specialist assessment due to pancreatitis risk, and prescription-strength omega-3 preparations may be considered as part of their management plan. Standard over-the-counter supplements are unlikely to achieve therapeutic triglyceride reduction in these cases.

Individuals who consume little or no oily fish due to dietary preferences, allergies or availability may consider supplementation to ensure adequate omega-3 intake, though increasing dietary fish consumption remains the preferred approach. Vegetarians and vegans might explore algae-based omega-3 supplements, which provide EPA and DHA without animal products. However, there is no official link established between low dietary omega-3 intake alone and the need for supplementation in otherwise healthy individuals.

People with established cardiovascular disease should discuss omega-3 supplementation with their GP or cardiologist. Whilst recent evidence does not strongly support routine supplementation for secondary prevention, individual circumstances may warrant consideration. Those taking anticoagulant or antiplatelet medications should exercise particular caution, as high-dose omega-3 fatty acids may theoretically increase bleeding risk, though clinically significant interactions appear uncommon at typical supplementation doses. People with a history of atrial fibrillation should be aware of the increased risk of arrhythmia recurrence observed with higher-dose omega-3 in clinical trials.

It is important to emphasise that fish oil supplements should not replace evidence-based cardiovascular treatments. Statins, antihypertensive medications, antiplatelet agents and lifestyle modifications including smoking cessation, regular physical activity and a balanced diet remain the cornerstone of cardiovascular disease prevention and management. Anyone considering fish oil supplements for heart health should consult their healthcare provider to ensure the approach aligns with their overall treatment plan and to identify any potential contraindications or interactions with existing medications.

Dosage, Safety and Potential Side Effects

Typical over-the-counter fish oil supplements contain between 250–1,000 mg of combined EPA and DHA per capsule, with manufacturers often recommending 1–3 capsules daily. For general health maintenance, doses providing approximately 250–500 mg combined EPA/DHA daily are commonly suggested, though optimal dosing for cardiovascular benefits remains uncertain. Prescription omega-3 preparations used for triglyceride reduction contain substantially higher doses (2–4 grams of EPA/DHA daily) and should only be used under medical supervision. Do not exceed the recommended dosage on product labels; many UK sources advise not exceeding 3g/day of EPA+DHA from supplements.

Fish oil supplements are generally well-tolerated, though several side effects may occur. The most common complaints include gastrointestinal symptoms such as fishy aftertaste, belching, nausea, loose stools and indigestion. Taking supplements with meals or using enteric-coated formulations may reduce these effects. Some people report a fishy body odour with higher doses. Less commonly, individuals may experience headaches or notice changes in taste perception. Higher doses of omega-3 supplements have been associated with increased risk of atrial fibrillation in clinical trials, so people with a history of this condition should discuss supplementation with their healthcare provider.

Safety considerations include potential interactions with anticoagulant and antiplatelet medications. Whilst clinically significant bleeding complications appear rare at typical supplementation doses, people taking warfarin, direct oral anticoagulants, aspirin or clopidogrel should inform their healthcare provider before starting fish oil supplements. Those with fish or shellfish allergies should exercise caution, though reactions to refined fish oil supplements appear uncommon. People with bleeding disorders or scheduled for surgery should discuss omega-3 supplementation with their doctor. DHA-containing omega-3 supplements may increase LDL-cholesterol in some individuals. Pregnant women should avoid cod liver oil supplements due to their vitamin A (retinol) content and should seek professional advice regarding omega-3 supplementation during pregnancy.

Quality and purity vary considerably between products. Reputable manufacturers test for contaminants including heavy metals (mercury, lead), polychlorinated biphenyls (PCBs) and dioxins. Look for products certified by independent testing organisations. In the UK, fish oil supplements are regulated as food supplements under food law (overseen by the Food Standards Agency and local authorities), not as medicines. This means quality standards may differ from pharmaceutical products. Store supplements in a cool, dark place and check expiration dates, as omega-3 fatty acids can oxidise over time, reducing efficacy and potentially producing harmful compounds. If you experience persistent side effects, report them via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or the Yellow Card app) and contact your GP or pharmacist for advice.

Alternatives to Fish Oil for Heart Health

Dietary sources of omega-3 fatty acids represent the most evidence-based alternative to fish oil supplements. Consuming at least two portions of fish weekly, including one portion (approximately 140g) of oily fish such as salmon, mackerel, sardines, trout or herring, provides EPA and DHA alongside protein, vitamin D, selenium and other beneficial nutrients. This dietary approach aligns with current NICE (NG238) and NHS Eatwell Guide recommendations for cardiovascular health. For those concerned about sustainability, smaller oily fish like sardines and mackerel generally have lower environmental impact than larger species.

For individuals following plant-based diets, alpha-linolenic acid (ALA) from sources including flaxseeds, chia seeds, walnuts, hemp seeds and rapeseed oil provides an omega-3 precursor. However, conversion of ALA to EPA and DHA in the human body is limited (typically less than 10%), making it a less efficient source. Algae-based supplements offer a direct source of EPA and DHA suitable for vegetarians and vegans, derived from the microalgae that fish consume to obtain their omega-3 content.

Evidence-based cardiovascular interventions that may provide greater benefit than fish oil supplementation include:

• Mediterranean-style dietary patterns emphasising vegetables, fruits, whole grains, legumes, nuts, olive oil and moderate fish consumption

• Regular physical activity (at least 150 minutes of moderate-intensity exercise weekly)

• Smoking cessation and limiting alcohol consumption (no more than 14 units per week)

• Blood pressure management through dietary sodium reduction, weight management and medication when appropriate

• Statin therapy for those meeting treatment criteria based on cardiovascular risk assessment, as outlined in NICE guidance (NG238)

Other supplements sometimes promoted for heart health, including coenzyme Q10, garlic supplements and red yeast rice, have limited or inconsistent evidence for cardiovascular benefit. Before considering any supplement for heart health, discuss your cardiovascular risk factors with your GP, who can provide personalised advice based on your medical history, current medications and overall health status. A comprehensive approach addressing multiple modifiable risk factors typically provides greater cardiovascular benefit than any single supplement.

Frequently Asked Questions